Atomoxetine - Eli Lilly and Company
At a glance
- Drug Originator Eli Lilly and Company
- Drug Class Antidementias; Antidepressants; Antiparkinsonians; Behavioural disorder therapies; Propylamines
- Mechanism of Action Adrenergic uptake inhibitors
- USA Patent Applicants LILLY
- USA Patents 1
- NDAs 1
- Patent Applications 4,009
Table of Contents
Disclaimer